R. Löser

876 total citations
30 papers, 704 citations indexed

About

R. Löser is a scholar working on Molecular Biology, Surgery and Genetics. According to data from OpenAlex, R. Löser has authored 30 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Surgery and 6 papers in Genetics. Recurrent topics in R. Löser's work include Cholesterol and Lipid Metabolism (8 papers), Estrogen and related hormone effects (6 papers) and Lipoproteins and Cardiovascular Health (4 papers). R. Löser is often cited by papers focused on Cholesterol and Lipid Metabolism (8 papers), Estrogen and related hormone effects (6 papers) and Lipoproteins and Cardiovascular Health (4 papers). R. Löser collaborates with scholars based in Germany, Switzerland and United States. R. Löser's co-authors include Benno Rattel, Max Hasmann, Katja Wosikowski, Urs Eppenberger, N Breiter, N. Esser, Joachim Drevs, K. Seibel, Hildebert Wagner and Karin Mattern and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Lipid Research and International Journal of Cancer.

In The Last Decade

R. Löser

29 papers receiving 668 citations

Peers

Countries citing papers authored by R. Löser

Since Specialization

Citations

This map shows the geographic impact of R. Löser's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Löser with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Löser more than expected).

Fields of papers citing papers by R. Löser

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Löser. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Löser. The network helps show where R. Löser may publish in the future.

Co-authorship network of co-authors of R. Löser

This figure shows the co-authorship network connecting the top 25 collaborators of R. Löser. A scholar is included among the top collaborators of R. Löser based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Löser. R. Löser is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Time-of-intake (morning versus evening) of extended-release fluvastatin in hyperlipemic patients is without influence on the pharmacodynamics (mevalonic acid excretion) and pharmacokinetics 2007 ·International Journal of Clinical Pharmacology and Therapeutics ·(unknown), C. Abletshauser, Wolfgang Erwa, R. Löser, (unknown), Winfried März	8
2	Antiangiogenic potency of FK866/K22.175, a new inhibitor of intracellular NAD biosynthesis, in murine renal cell carcinoma. 2004 ·PubMed ·Joachim Drevs, R. Löser, Benno Rattel, N. Esser	58
3	M.510 Fluvastatin ER formulation reduces cholesterol biosynthesis independent of daytime of administration 2004 ·Atherosclerosis Supplements ·(unknown), Winfried März, C. Abletshauser, Wolfgang Erwa, R. Löser	1
4	Polyethylene Glycol Conjugates of Methotrexate Varying in Their Molecular Weight from MW 750 to MW 40000: Synthesis, Characterization, and Structure−Activity Relationships in Vitro and in Vivo 2002 ·Bioconjugate Chemistry ·(unknown), (unknown), R. Löser, N Breiter, Ralf Hanselmann, Rolf Mülhaupt, Clemens Unger, Felix Kratz	82
5	WK175, a novel antitumor agent, decreases the intracellular nicotinamide adenine dinucleotide concentration and induces the apoptotic cascade in human leukemia cells. 2002 ·PubMed ·Katja Wosikowski, Karin Mattern, (unknown), Max Hasmann, Benno Rattel, R. Löser	79
6	The effects of lifibrol (K12.148) on the cholesterol metabolism of cultured cells: evidence for sterol independent stimulation of the LDL receptor pathway 2000 ·Atherosclerosis ·Hubert Scharnagl, (unknown), R. Löser, Markus Nauck, (unknown), Nikola Jeck, Heinrich Wieland, Werner Groß, Winfried März	6
7	Effects of pravastatin on cholesterol metabolism of cholesterol‐fed heterozygous WHHL rabbits 1998 ·British Journal of Pharmacology ·(unknown), (unknown), (unknown), Gerhard Lang, (unknown), R. Löser, (unknown), Axel Niendorf	4
8	A novel assay for cytosolic 3-hydroxy-3-methylglutaryl-coenzyme A synthase activity using reversed-phase ion-pair chromatography: demonstration that Lifibrol (K12.148) modulates the enzyme activity. 1995 ·Journal of Lipid Research ·Hubert Scharnagl, Winfried März, (unknown), R. Löser, Gross Wl	13
9	Preclinical data for Droloxifene 1994 ·Cancer Letters ·Max Hasmann, Benno Rattel, R. Löser	48
10	Inhibition of growth‐factor‐activated proliferation by anti‐estrogens and effects on early gene expression of mcf‐7 cells 1993 ·International Journal of Cancer ·Katja Wosikowski, Willy Küng, Max Hasmann, R. Löser, Urs Eppenberger	40
11	Inhibition of cholesterol synthesis in vitro by extracts and isolated compounds prepared from garlic and wild garlic 1992 ·Atherosclerosis ·A. Sendl, (unknown), R. Löser, (unknown), Hildebert Wagner	67
12	Flow cytometric analysis of vims-infected cells and its potential use for screening antiviral agents 1990 ·Journal of Virological Methods ·Olivia Steele‐Mortimer, H. Meier-Ewert, R. Löser, Max Hasmann	17
13	Effects of the hypocholesterolemic compound K12.148 on serum lipids and parameters of clinical chemistry of pigs 1990 ·Journal of Animal Physiology and Animal Nutrition ·(unknown), M. Kirchgeßner, R. Löser, K. Seibel, (unknown), W. Erhardt, R. Ascherl, (unknown)	6
14	Circadian variation of the hypocholesterolemic effect of K13.004 in rats 1987 ·Atherosclerosis ·(unknown), R. Löser, (unknown)	4
15	In vivo and in vitro antiestrogenic action of 3-hydroxytamoxifen, tamoxifen and 4-hydroxytamoxifen 1985 ·European Journal of Cancer and Clinical Oncology ·R. Löser, (unknown), Werner Roos, Urs Eppenberger	46
16	In Vitro Characterization of New Antiestrogens in Human Mammary Tumor Cells 1984 ·Recent results in cancer research ·Urs Eppenberger, W. Küng, R. Löser, Werner Roos	2
17	The hypocholesterolemic effect of terbufibrol and other drugs in normal and hypercholesterolemic baboons 1979 ·Atherosclerosis ·A.N. Howard, (unknown), R. Löser, (unknown)	4
18	The pressure-resistance relationships of regional resistances within the coronary circulation and the steal phenomenon 1978 ·Basic Research in Cardiology ·(unknown), W. Lochner, R. Löser, (unknown)	5
19	Free-Flow Electrophoresis II. Analysis of the Method with Respect to Preparative Gell Separation 1975 ·Hoppe-Seyler´s Zeitschrift für physiologische Chemie ·K. Zeiller, R. Löser, G. Pascher, K. Hannig	49
20	Inhibition of R-factor transfer by levallorphan 1971 ·Biochemical and Biophysical Research Communications ·R. Löser, P Boquet, R. Röschenthaler	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact